The evolving role of sirolimus in renal transplantation

被引：17
作者：
Dupont, P [1 ]
Warrens, AN [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England
来源：
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2003年 / 96卷 / 06期
关键词：
D O I：
10.1093/qjmed/hcg072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In summary, sirolimus is an exciting addition to our immunosuppressive armamentarium. There are encouraging early data suggesting that this drug may have significant advantages over existing agents, namely the promotion of tolerance, reduction in chronic allograft vasculopathy and avoidance of toxic effects of other immunosuppressive drugs. If further large clinical studies can confirm its safety and efficacy over a longer duration of follow-up this will no doubt promote its more widespread adoption.
引用
收藏
页码：401 / 409
页数：9
相关论文
共 65 条
[1]  
AKSELBAND Y, 1991, TRANSPLANT P, V23, P2833
[2]  
ANDERSSON J, 1992, IMMUNOLOGY, V75, P136
[3]   Cold ischemia time: An independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft [J].
Bryan, CF ;
Luger, AM ;
Martinez, J ;
Muruve, N ;
Nelson, PW ;
Pierce, GE ;
Ross, G ;
Shield, CF ;
Warady, BA ;
Aeder, MI ;
Helling, TS .
TRANSPLANTATION, 2001, 71 (07) :875-879
[4]  
CALNE RY, 1989, LANCET, V2, P227
[5]  
CHEN H, 1992, TRANSPLANT P, V24, P1157
[6]   REVERSAL OF ONGOING HEART, KIDNEY, AND PANCREAS ALLOGRAFT-REJECTION AND SUPPRESSION OF ACCELERATED HEART ALLOGRAFT-REJECTION IN THE RAT BY RAPAMYCIN [J].
CHEN, HF ;
WU, JP ;
XU, DS ;
LUO, HY ;
DALOZE, PM .
TRANSPLANTATION, 1993, 56 (03) :661-666
[7]  
COLLIER DS, 1990, TRANSPLANT P, V22, P1674
[8]  
COLLIER DS, 1991, TRANSPLANT P, V23, P2246
[9]   Recurrence of hemolytic-uremic syndrome in renal transplant recipients - A meta-analysis [J].
Ducloux, D ;
Rebibou, JM ;
Semhoun-Ducloux, S ;
Jamali, M ;
Fournier, V ;
Bresson-Vautrin, C ;
Chalopin, JM .
TRANSPLANTATION, 1998, 65 (10) :1405-1407
[10]  
DUMONT FJ, 1990, J IMMUNOL, V144, P251
1234567